跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-GALANTAMINE MR galantamine (as hydrobromide) 24 mg modified release capsules blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
APO-GALANTAMINE MR galantamine (as hydrobromide) 24 mg modified release capsules blister pack
Approved
STANDARD
APO-GALANTAMINE MR galantamine (as hydrobromide) 24 mg modified release capsules blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
df660e845fa86098
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
df660e845fa86098
Product Name
APO-GALANTAMINE MR galantamine (as hydrobromide) 24 mg modified release capsules blister pack
Artg Id
182034
Artg Name
APO-GALANTAMINE MR galantamine (as hydrobromide) 24 mg modified release capsules blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2012-01-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/44e34e1e0ffb67bb79d306ada809b638.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/774aa241a3580932e8d43e17866d857f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
df660e845fa86098
Type
Standard
Back to TGA Approvals